ACBFF - Aurora Cannabis Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
11.33562
+0.81562 (+7.75%)
As of 1:18PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close10.52000
Open10.87500
Bid0.00000 x 0
Ask0.00000 x 0
Day's Range10.76773 - 11.45000
52 Week Range2.11000 - 12.30000
Volume9,926,026
Avg. Volume6,854,878
Market Cap10.896B
Beta (3Y Monthly)2.00
PE Ratio (TTM)100.32
EPS (TTM)0.11300
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Cannabis edibles will soon be a $4 billion business
    Yahoo Finance3 hours ago

    Cannabis edibles will soon be a $4 billion business

    The cannabis business has been on fire lately, and there’s one area in the space that could still have serious potential to heat up: edibles, according to a new report by Arcview Market Research.

  • ACCESSWIRE3 hours ago

    These Biotech and Cannabis Stocks Have Skyrocketing Potential

    HENDERSON, NV / ACCESSWIRE / October 15, 2018 / A fascinating biotechnology firm PPCB (Propanc Biopharma, Inc.) erupted for over 7000% in the between late August and early September going from a low of $0.0039 to a high of over $0.28, the stock is still holding a substantial gain of 1795% as of the close on Friday. PPCB may start receiving increased attention from the street at any moment. PPCB has a 52 week high of $0.77.

  • ACCESSWIRE3 hours ago

    3 Cannabis Stocks To Add To Your Watch List This Month

    CORAL GABLES, FL / ACCESSWIRE / October 15, 2018 / Rep. Dana Rohrabacher, California Republican, stated this past Thursday that President Trump has the intentions to work towards legalizing medical marijuana on a federal level following next month's midterm races. The Trump administration has made a "solid commitment" to change marijuana regulations, and the president has expressed his views in support of federally legalizing the cannabis for medical use, Mr. Rohrabacher told Fox Business Channel. "I have been talking to people inside the White House who know and inside the president's entourage," Mr. Rohrabacher stated, Fox Business reported.

  • Cannabis Sector Ended in the Green amid Last Week’s Sell-Off
    Market Realist5 hours ago

    Cannabis Sector Ended in the Green amid Last Week’s Sell-Off

    Last week, the overall cannabis sector ended in positive territory. The Horizons Marijuana Life Sciences ETF (HMMJ) rose 3.1% between October 5 and October 12. The Emerging Marijuana Growers Index ETF (HMJR) rose 2.2% during the same period. Let’s look at how the cannabis stocks performed last week.

  • Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group
    Motley Fool23 hours ago

    Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group

    Is bigger better in a battle between these two Canadian marijuana stocks?

  • 3 Marijuana Milestones Aurora Cannabis Stock Must Reach
    Motley Foolyesterday

    3 Marijuana Milestones Aurora Cannabis Stock Must Reach

    Find out what's most critical for the Canadian cannabis company to achieve.

  • This $372 Million Windfall for Aurora Cannabis Could Be Just the Beginning
    Motley Fool2 days ago

    This $372 Million Windfall for Aurora Cannabis Could Be Just the Beginning

    Find out how the number could grow even further.

  • Aurora Cannabis IPO: Should Marijuana Investors Expect a Big Jump?
    Motley Fool3 days ago

    Aurora Cannabis IPO: Should Marijuana Investors Expect a Big Jump?

    The marijuana stock's NYSE debut won't be a standard initial public offering.

  • InvestorPlace3 days ago

    Are Pot Stocks Heading Into a “Sell The News” Event?

    Pot stocks have been absolutely on fire over the past few months. It all started with beverage giant Constellation Brands (NYSE:STZ) pouring $4 billion into leading cannabis company Canopy Growth (NYSE:CGC) on August 15, a sign that big money was finally moving into the nascent cannabis sector. Pot stocks have been on fire ever since.

  • ACCESSWIRE4 days ago

    Cannabis and Biotech Stocks That Have Run Parabolically

    HENDERSON, NV / ACCESSWIRE / October 11, 2018 / Cannabis and Biotech companies have been receiving increased attention from the street as of late. One particular company that has caught significant attention ...

  • Is Aurora Cannabis a Better Marijuana Stock Than Canopy Growth?
    Motley Fool4 days ago

    Is Aurora Cannabis a Better Marijuana Stock Than Canopy Growth?

    If I could buy only one of these marijuana stocks, here's the one I'd pick.

  • Tobacco Companies and Their Newfound Interest in Cannabis
    Market Realist4 days ago

    Tobacco Companies and Their Newfound Interest in Cannabis

    On October 10, Reuters reported that tobacco giant Altria is in discussions with Aphria (APHQF) about acquiring a stake in the company. The initial round of investments would give Altria a minority stake in Aphria with the possibility of acquiring a majority stake. Following the news, Aphria stock gained 15.2% to close the day at 20.1 Canadian dollars as investors rushed to capitalize on the opportunity.

  • Canopy Growth to Create Safe-Driving Awareness with Uber, MADD
    Market Realist4 days ago

    Canopy Growth to Create Safe-Driving Awareness with Uber, MADD

    Cannabis for recreational adult use will be legal in Canada on October 17. While enthusiasts are anticipating the big day, enforcement authorities in Canada are bracing for unanticipated challenges. Aware of those challenges, Canopy Growth (CGC) (WEED) is partnering with Uber and MADD in a national campaign to create awareness related to impaired driving.

  • Canopy Growth Exporting Medical Cannabis for US Research
    Market Realist4 days ago

    Canopy Growth Exporting Medical Cannabis for US Research

    On October 9, Canopy Growth (CGC) (WEED) announced that it has completed a legal transfer of medical cannabis to the United States for the sole purpose of research related to medical product development. Canopy Growth is the second company to do so after Tilray (TLRY) announced last month that it received approval from US regulators to export its cannabis products for medical research.